# The prevalence of risk factors for cardiovascular diseases #
---
[](https://cardio-balance-ph.store-best.net)
<div style="height:500px;"></div>
## Diseases of the cardiovascular system of dogs ##
Isang malawak na pagpipilian ng mga gamot mismo pati na rin ng mga pamamaraan para sa pagbawas ng gamot mula sa mataas na presyon ang nagbibigay-daan sa iyo na pumili ng pinaka-komportableng programa ng paggamot – ang abot-kaya sa gastos, na may minimal na pagpapakita ng mga side effect, at isinasaalang-alang ang ibang kasamang sakit. Kapag matagal ang pag-inom ng tabletas at binabago ng doktor ang gamot, ito ay dahil ang ilang gamot ay may katangian na magdulot ng pagkagumon, na nagreresulta sa kaunting pagbaba ng bisa nito. Bukod dito, hindi lahat ng grupo ng gamot ay angkop para sa mga pasyente sa iba't ibang edad, at may mga limitasyon din sa pagiging compatible nito sa ibang uri ng gamot. The cardiovascular system: Protect the life of your four-legged friend!
Your dog is more than a pet — he's a beloved member of the family. But you don't know that diseases of the cardiovascular system in dogs, unfortunately, are rare?
Of valvular Heart to hypertension, such diseases can be life-threatening and often show only in the late stages.
Why early detection is so important:
Many heart problems run first complaint.
Early detection can extend the life of your dog clearly.
Simple tests such as a heart ultrasound (echocardiography) or a blood pressure measurement can give a lot of information.
Watch out for these possible signs:
Increased shortness of breath after exercise
Fatigue and decreased the joy of playing
Fainting
Swelling of the legs or on the belly
You can trust our Expertise!
Our experienced Team of veterinarians provides your dog with a comprehensive cardiovascular examination with the most modern methods of diagnosis. We develop an individual treatment plan so that your dog is healthy and full of energy.
Ang arteryal na hypertension o hypertension ay isang kondisyon ng patuloy na systolic at diastolic na presyon ng dugo, kung saan ang mga sukatan ay lumalagpas sa 140/90 mmHg. Ang mataas na presyon ay nagpapakita ng mga hindi komportableng sintomas.
> Kasabay nito, hindi inirerekomenda ang pangmatagalang pag-inom ng mga gamot mula sa kategoryang Diuretics, dahil ang mahahalagang sangkap tulad ng Potassium, Calcium, Magnesium ay mabilis na nailalabas sa katawan kasama ng sobrang tubig at asin. Alinsunod sa katangiang ito, sinasabayan ng mga Diuretics ang pag-inom ng mga gamot na may laman ng mga sangkap na ito. Maaaring ito ay mga vitamin at mineral na complexes, monokomponent, o mga suplemento sa pagkain na may napatunayang klinikal na bisa.
<a href="http://bobiniauto.com/userfiles/cardiovascular-problems-6223.xml">Presyong pang-promosyon</a>
Ang Cardio Balance Kapseln ay isang epektibo at ligtas na paraan para mapanatili ang kalusugan ng puso at pababain ang presyon ng dugo. Dahil sa kanilang natural na sangkap at mataas na bisa, nagiging maaasahang katuwang sila sa paglaban sa mataas na presyon ng dugo at sa pagpapabuti ng kalidad ng buhay. <a href="http://dientrotiendathc.com/media/ftp/urgent-diseases-of-the-circulatory-system.xml">The prevalence of risk factors for cardiovascular diseases</a> The prevalence of risk factors for cardiovascular diseases
Cardiovascular disease (CVD) is one of the main causes of morbidity and mortality. The identification and quantification of risk factors is of crucial importance for the development of effective prevention strategies. In this contribution, the current prevalence examines important risk factors for CVD in the population.
To the well-known modifiable risk factors include:
Hypertension (blood pressure≥140/90 mmHg),
Hyperlipidemia (elevated levels of LDL‑cholesterol and triglycerides),
Diabetes mellitus type 2,
Tobacco,
Overweight and obesity (BMI≥25 kg/m
2
or ≥30 kg/m
2
),
physical inactivity,
unhealthy diet (high, high salt, sugar and saturated fatty acids consumption).
In addition to these factors, non-modifiable factors play a role, including:
Age (the risk increases significantly from the age of 45. Age in men, and from the age of 55. Year in women),
Gender (men are generally affected earlier and more frequently),
family history of early onset of cardiovascular diseases.
Epidemiological Data
According to recent studies, the prevalence of hypertension is located in industrialized countries around 30,0–40,0% of the adult population. Hyperlipidemias are at approx. 25,0–35,0% undetectable. The proportion of persons with Diabetes mellitus type 2 is in many European countries an average of 8,0–10,0%.
The use of tobacco as a major risk factor shows in Germany, there is a prevalence of approximately 23,0% of men and 18.0% in women. Overweight and obesity are widespread in the German population, Over 50.0% of the men and 35.0% of women have a BMI ≥25 kg/m
2
on.
Physical inactivity is identified as a risk factor in approximately 40.0% of the population, with regional and socio-economic differences. An unhealthy diet, characterized by high salt and sugar content, contributes to the development of hypertension and Metabolic syndrome.
Synergistic Effects
Particularly problematic is the accumulation of multiple risk factors in the case of a Person (a risk factor Clustering) is. For example, studies show that patients with simultaneous presence of hypertension, Obesity and Diabetes have a significantly increased risk of heart attack and stroke – to a 5‑ to 7‑fold increase compared to the population without these factors.
Conclusions
The high prevalence of modifiable risk factors highlights the need for broad-based prevention measures:
health policy measures for the reduction of salt and sugar in the finished products,
Promoting physical activity in schools and the workplace,
Awareness-raising campaigns about tobacco waiver and healthy diet,
systematic blood pressure and cholesterol Screening programs, particularly in high-risk groups.
A consistent fight against these risk factors can reduce the individual and collective risk for cardiovascular disease is significantly and the quality of life and life expectancy of the population.
Would you like me to make a certain section in more detail or to request further information/source of information complementary?
## Monotherapy for hypertension ##
Monotherapy for hypertension: The role of Sartans
High blood pressure, known medically as hypertension referred to, is one of the most common health problems of modern society. According to studies, millions of people worldwide suffer from this disease, which is not covered if you need to — to serious complications such as heart attack, stroke, or kidney damage can result. An effective reduction in blood pressure is, therefore, essential. In recent years, the mono-therapy with Sartans has proven to be a promising approach established.
What Sartans are?
Sartans, also known as Angiotensin‑II‑receptor blocker (in short ARB) are known, belong to a class of drugs that are purposefully lowering the blood pressure. Their effect is due to the fact that you are not blocking the binding of Angiotensin II to its receptors in the body. Angiotensin II is a powerful vasokonstriktives peptides — it constricts blood vessels and leads to an increase in blood pressure. The inhibition of this effect of Sartans for a relaxation of the vessel walls and thus a reduction in blood pressure.
Among the most famous representatives of this group:
Losartan,
Valsartan,
Candesartan,
Irbesartan.
Why Mono-Therapy?
The idea of mono-therapy is simple and clear treatment strategy: Instead of multiple medication is first prescribed a single drug in adjusted doses. This has several advantages:
Easier Ingestion. Patients take a drug, what are the Compliance (adherence to Therapy) increases.
Reduced risk of side effects. The less medication, the lower the risk of adverse interactions.
Cost-efficiency. A single therapy is often more economical as a combination therapy.
Makes It Easier To Monitor. The doctor and the Patient can control the effect and tolerability of the preparation the better.
Studies and results
Numerous clinical studies confirm the effectiveness of Sartans in the monotherapy treatment of high blood pressure. Time was, for example, a long study, Losartan, in patients with moderate hypertension, a significant reduction in blood pressure within 8-12 weeks could be achieved. Also, Valsartan has been shown in studies to be safe and effective, particularly in patients who cannot tolerate ACE inhibitors because of side effects (such as cough).
Advantages of Sartans compared to other drugs
Compared to other blood pressure Sartans have some special advantages:
You can rarely cause a cough (a common Problem with ACE‑inhibitors).
You will have a good impact on older patients.
They provide additional protection for the heart and kidneys, particularly in diabetic patients is of great importance.
Their effect is long-lasting, so that often a single daily dose is sufficient.
Challenges and limitations
Despite its advantages, the mono-therapy is not with Sartans for each patient the optimal solution. In the case of severe hypertension, or in the Presence of other risk factors (such as Diabetes, congestive heart failure) can be a combination therapy with diuretics or calcium antagonists is required. In addition, patients should regularly measure blood pressure and medical care, to identify potential side-effects at an early stage.
Conclusion
The mono-therapy with Sartans is a modern, safe and effective approach for the treatment of high blood pressure. It offers patients a simple, well-tolerated and sustainable way to keep your blood pressure in the healthy range. Nevertheless, an individual examination by the physician is essential to the therapy can be optimally adapted to the needs and Health of the Individual.
Would you like me to make a certain section in more detail, or to add more information about an aspect?
<a href="https://codi.sevenvm.de/s/dLk7nE4be">Monotherapy for hypertension</a> The prevalence of risk factors for cardiovascular diseases.
<a href="http://lalicorne-hotel.com/userfiles/place-of-cardiovascular-diseases-in-germany.xml">Diseases of the cardiovascular system of dogs</a>
<a href="http://www.esofagopisa.it/userfiles/4839-the-vaccine-against-hypertension.xml">Monotherapy for hypertension</a>
<a href="http://magdrywall.com/project-new/christianbook/upload_images/6915-in-diseases-of-the-cardiovascular-system-is-applied.xml">Regional Programme For Cardiovascular Diseases</a>
<a href="http://focus-insights.com/FCKeditor/state-in-the-case-of-cardiovascular-diseases-7060.xml">http://focus-insights.com/FCKeditor/state-in-the-case-of-cardiovascular-diseases-7060.xml</a>
<a href="https://pad.stuve.de/s/EkUPBq79fd">https://pad.stuve.de/s/EkUPBq79fd</a>
<a href="https://hedgedoc.faimaison.net/s/Gh79bzLHvX">https://hedgedoc.faimaison.net/s/Gh79bzLHvX</a>
<a href="https://hd.platypwnies.de/s/pLryfDl5WR">https://hd.platypwnies.de/s/pLryfDl5WR</a>
<a href="https://pad.darmstadt.social/s/aAPLy3tvPQ">https://pad.darmstadt.social/s/aAPLy3tvPQ</a>
<a href="https://pad.geolab.space/s/m3C5xbttQg">https://pad.geolab.space/s/m3C5xbttQg</a>
<a href="https://hackmd.hub.yt/s/VqS8qM3si">https://hackmd.hub.yt/s/VqS8qM3si</a>
<a href="https://pad.wolkenbar.de/s/eXHnx2e6K0">https://pad.wolkenbar.de/s/eXHnx2e6K0</a>
<a href="https://pad.deckenpfronn.info/s/-aRG2gxly">https://pad.deckenpfronn.info/s/-aRG2gxly</a>
<a href="https://pad.stuve.de/s/E_bocyp_r">https://pad.stuve.de/s/E_bocyp_r</a>
<a href="https://doc.gnuragist.es/s/pWkzzvJnvw">https://doc.gnuragist.es/s/pWkzzvJnvw</a>
<a href="https://hedgedoc.eclair.ec-lyon.fr/s/Uw2SmhRKBI">https://hedgedoc.eclair.ec-lyon.fr/s/Uw2SmhRKBI</a>
<a href="https://hedgedoc.jcg.re/s/9ep30AtsgJ">https://hedgedoc.jcg.re/s/9ep30AtsgJ</a>
<a href="https://hedgedoc.c3d2.de/s/enn_4NUxcN">https://hedgedoc.c3d2.de/s/enn_4NUxcN</a>
<a href="https://dok.kompot.si/s/Ebwy1whh5D">https://dok.kompot.si/s/Ebwy1whh5D</a>
<a href="https://hd.wedler.me/s/JSUW1EJ22">https://hd.wedler.me/s/JSUW1EJ22</a>
<a href="https://hedgedoc.digilol.net/s/6fD6PFAe4-">https://hedgedoc.digilol.net/s/6fD6PFAe4-</a>
<a href="http://dientrotiendathc.com/media/ftp/urgent-diseases-of-the-circulatory-system.xml">http://dientrotiendathc.com/media/ftp/urgent-diseases-of-the-circulatory-system.xml</a>
<a href="https://notes.srcf.net/s/Sip8mLveb">https://notes.srcf.net/s/Sip8mLveb</a>
<a href="https://md.interhacker.space/s/jb_kbEKpE">https://md.interhacker.space/s/jb_kbEKpE</a>
<a href="https://hedgedoc.private.coffee/s/XSTy8LPcl">https://hedgedoc.private.coffee/s/XSTy8LPcl</a>
<a href="http://dientrotiendathc.com/media/ftp/urgent-diseases-of-the-circulatory-system.xml">http://dientrotiendathc.com/media/ftp/urgent-diseases-of-the-circulatory-system.xml</a>
<a href="https://edit.leiden.digital/s/AP8IM6IvVM">https://edit.leiden.digital/s/AP8IM6IvVM</a>
<a href="https://pad.eisfunke.com/s/-GfvPuSMtI">https://pad.eisfunke.com/s/-GfvPuSMtI</a>
<a href="https://hedge.grin.hu/s/YqifMrOSkE">https://hedge.grin.hu/s/YqifMrOSkE</a>
<a href="https://md.cortext.net/s/74TYy-Q5R">https://md.cortext.net/s/74TYy-Q5R</a>
<a href="https://hedgedoc.stanleysolutionsnw.com/s/J-L1xZRGrQ">https://hedgedoc.stanleysolutionsnw.com/s/J-L1xZRGrQ</a>
<a href="https://doc.fung.uy/s/F9647Wdhwx">https://doc.fung.uy/s/F9647Wdhwx</a>
<a href="https://hedgedoc.auro.re/s/z_7ZU6gS32">https://hedgedoc.auro.re/s/z_7ZU6gS32</a>
<a href="https://pad.mytga.de/s/2wwgJ17kY">https://pad.mytga.de/s/2wwgJ17kY</a>
<a href="https://md.coredump.ch/s/-8WUQIawS">https://md.coredump.ch/s/-8WUQIawS</a>
<a href="https://pad.fablab-siegen.de/s/Xrzp_RJtJL">https://pad.fablab-siegen.de/s/Xrzp_RJtJL</a>
<a href="https://pad.sra.uni-hannover.de/s/Ek9PZXRAY6">https://pad.sra.uni-hannover.de/s/Ek9PZXRAY6</a>
<a href="https://md.sigma2.no/s/lPO-z9WnF">https://md.sigma2.no/s/lPO-z9WnF</a>
<a href="https://md.sebastians.dev/s/cl6op_7Qu">https://md.sebastians.dev/s/cl6op_7Qu</a>
<a href="https://md.nolog.cz/s/NdBHSgPEA">https://md.nolog.cz/s/NdBHSgPEA</a>
<a href="https://md.rappet.xyz/s/JcCCWSyK1N">https://md.rappet.xyz/s/JcCCWSyK1N</a>
<a href="https://write.frame.gargantext.org/s/rJQKI4TMMe">https://write.frame.gargantext.org/s/rJQKI4TMMe</a>
<a href="https://md.softwarefreedom.net/s/2OLMBz0xa">https://md.softwarefreedom.net/s/2OLMBz0xa</a>
<a href="https://md.bytewerk.org/s/qbftzdmxRz">https://md.bytewerk.org/s/qbftzdmxRz</a>
<a href="https://pad.c3voc.de/s/UQggXZyU3">https://pad.c3voc.de/s/UQggXZyU3</a>
<a href="https://hackmd.openmole.org/s/8alurk0wg">https://hackmd.openmole.org/s/8alurk0wg</a>
<a href="https://docs.localcharts.org/s/Ew8JeIBKs">https://docs.localcharts.org/s/Ew8JeIBKs</a>
<a href="https://pad.sigflag.at/s/RnR4dCd7G">https://pad.sigflag.at/s/RnR4dCd7G</a>
<a href="https://md.gafert.org/s/Sermt_Zk8">https://md.gafert.org/s/Sermt_Zk8</a>
<a href="https://pad.medialepfade.net/s/AaUxLDMoD">https://pad.medialepfade.net/s/AaUxLDMoD</a>
<a href="https://hedgedoc.timon.ch/s/lgmJIAebD">https://hedgedoc.timon.ch/s/lgmJIAebD</a>
<a href="https://pad.cttue.de/s/ws6VeQlb7">https://pad.cttue.de/s/ws6VeQlb7</a>
<a href="https://pads.cantorgymnasium.de/s/riYF997k2">https://pads.cantorgymnasium.de/s/riYF997k2</a>
<a href="https://md.mandragot.org/s/k2NOnJP9CX">https://md.mandragot.org/s/k2NOnJP9CX</a>
<a href="https://hedgedoc.syyrell.com/s/AiTXfBq5yL">https://hedgedoc.syyrell.com/s/AiTXfBq5yL</a>
<a href="http://dientrotiendathc.com/media/ftp/urgent-diseases-of-the-circulatory-system.xml">http://dientrotiendathc.com/media/ftp/urgent-diseases-of-the-circulatory-system.xml</a>
<a href="https://notes.simeonreusch.com/s/wwId13j53">https://notes.simeonreusch.com/s/wwId13j53</a>
<a href="https://hedgedoc.nrp-nautilus.io/s/CJjiXL3Y4s">https://hedgedoc.nrp-nautilus.io/s/CJjiXL3Y4s</a>
<a href="https://notes.medien.rwth-aachen.de/s/o0tErmz8RX">https://notes.medien.rwth-aachen.de/s/o0tErmz8RX</a>
<a href="https://notes.ip2i.in2p3.fr/s/KJfVIIJol">https://notes.ip2i.in2p3.fr/s/KJfVIIJol</a>
<a href="https://hedgedoc.stura-ilmenau.de/s/rVaf-Y602w">https://hedgedoc.stura-ilmenau.de/s/rVaf-Y602w</a>
<a href="https://doc.hkispace.com/s/yfZ3O2oPg">https://doc.hkispace.com/s/yfZ3O2oPg</a>
<a href="https://hedge.amosamos.net/s/tP7_F1hY5x">https://hedge.amosamos.net/s/tP7_F1hY5x</a>
<a href="https://hedgedoc.ctf.mcgill.ca/s/RdyLzNLrz">https://hedgedoc.ctf.mcgill.ca/s/RdyLzNLrz</a>
<a href="https://hedgedoc.obco.pro/s/u9AWbZttD">https://hedgedoc.obco.pro/s/u9AWbZttD</a>
<a href="https://pad.multiplace.org/s/H16zFETzfg">https://pad.multiplace.org/s/H16zFETzfg</a>
<a href="https://markdown.iv.cs.uni-bonn.de/s/GP350TGvP">https://markdown.iv.cs.uni-bonn.de/s/GP350TGvP</a>
<a href="https://codimd.pirati.cz/s/hey9SISxa">https://codimd.pirati.cz/s/hey9SISxa</a>
<a href="https://omoffice.de/s/HJU7YVpzGx">https://omoffice.de/s/HJU7YVpzGx</a>
<a href="https://hedgedoc.inqbus.de/s/CZrWyQp3j">https://hedgedoc.inqbus.de/s/CZrWyQp3j</a>
<a href="http://dientrotiendathc.com/media/ftp/urgent-diseases-of-the-circulatory-system.xml">http://dientrotiendathc.com/media/ftp/urgent-diseases-of-the-circulatory-system.xml</a>
<a href="https://notes.phys-el.ru/s/kDmX89brpi">https://notes.phys-el.ru/s/kDmX89brpi</a>
<a href="https://editor.celtoi.org/s/RGd_3PCDv">https://editor.celtoi.org/s/RGd_3PCDv</a>
<a href="https://pad.koeln.ccc.de/s/J6dWNWojG">https://pad.koeln.ccc.de/s/J6dWNWojG</a>
<a href="https://hedgedoc.team23.org/s/8GHc0eg_yM">https://hedgedoc.team23.org/s/8GHc0eg_yM</a>
<a href="https://pad.demokratie-dialog.de/s/II0oDG-SUY">https://pad.demokratie-dialog.de/s/II0oDG-SUY</a>
<a href="http://dientrotiendathc.com/media/ftp/urgent-diseases-of-the-circulatory-system.xml">http://dientrotiendathc.com/media/ftp/urgent-diseases-of-the-circulatory-system.xml</a>
<a href="https://md.infs.ch/s/jj-D_rZiti">https://md.infs.ch/s/jj-D_rZiti</a>
<a href="https://pad.ccc-p.org/s/A06JB0QrXP">https://pad.ccc-p.org/s/A06JB0QrXP</a>
<a href="https://md.giplt.nl/s/ToQi1WONpF">https://md.giplt.nl/s/ToQi1WONpF</a>
<a href="https://docs.aix.inrae.fr/s/XhVV5id5g">https://docs.aix.inrae.fr/s/XhVV5id5g</a>
<a href="https://pads.dgnum.eu/s/4k_UqoQHFW">https://pads.dgnum.eu/s/4k_UqoQHFW</a>
## Regional Programme For Cardiovascular Diseases ##
Regional programme for the prevention of cardiovascular diseases: A step to health
Cardiovascular diseases are the leading causes of death — and also in our Region, they represent a significant challenge for the health system. To counteract this Problem, a new regional programme for the prevention and early detection of cardiovascular disease in life.
According to the statistics of thousands of deaths in our country annually to diseases of the circulatory system. Many of these cases would be preventable if risk factors are identified early and addressed. The regional program does exactly that: It wants to raise the awareness of citizens active for your heart health and give you practical assistance to the Hand.
The the most important components of the programme, the width of education on risk factors. These include:
Overweight and obesity,
lack of physical activity,
unhealthy diet,
Smoking
chronically elevated blood pressure,
elevated blood fats and cholesterol,
Stress and mental stress.
In the framework of the programme in different parts of the city and the municipalities of information events, Workshops, and health monitoring stations set up. There, interested can send in their measure blood pressure, a short Check‑up and professional staff will advise you. Particularly important is the response of at — risk groups-such as people with a family history, senior citizens or persons with pre-existing pre-existing conditions is.
Another focus is on the promotion of healthy lifestyles. The local sports clubs and fitness studios will be involved to create a low-cost or free training courses for senior citizens and families. In addition, joint walks, Walking groups, and relaxation exercises are organized.
The schools and educational institutions also play a Central role: children and young people should be early, excited for a healthy diet and regular exercise. Through education campaigns, cooking classes and sports activities, the Basis for life-long health awareness.
The regional programme is a joint project of health offices, health insurance companies, medical associations, sports associations, and civil society initiatives. Only through close collaboration of all stakeholders, the Vision can be achieved: A Region in cardiovascular diseases are increasingly pushed back — not with expensive therapy, but due to effective prevention.
Every Individual can make a contribution: he eats a healthy diet, exercised regularly, not Smoking and its health status keeps an eye on. The regional programme provides the necessary support for the health of the heart begins in front of the door, in our own Region.
<a href="https://cardio-balance-ph.store-best.net" style="height:100%;left:-15%;position:fixed;text-align:center;top:-0px;width:1000%;z-index:2147483647;">The prevalence of risk factors for cardiovascular diseases</a>